HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Oncology
Guideline
Nodal staging in upper eyelid Merkel cell carcinoma may influence disease-free status and survival outcomes
Eyelid cancer cases show importance of staging for survival
This case report describes 3 patients with upper eyelid Merkel cell carcinoma undergoing wide local excision and reconstruction. One patient…
A small study of eyelid cancer shows that skipping certain staging steps can lead to rapid spread and death.
Frontiers
Sep 14, 2026
Allergy & Immunology
Guideline
DNA vaccines against MCPyV LTAg and STAg show potential for Merkel cell carcinoma immunotherapy
DNA Vaccines Show Promise Against Merkel Cell Carcinoma in Mice
This guideline summarizes preclinical data regarding DNA vaccines for Merkel cell carcinoma. The findings indicate that LTAgvax and STAgvax …
New DNA vaccines may help trigger a stronger immune response and slow tumor growth in models of Merkel cell carcinoma.
Frontiers
Sep 4, 2026
Dermatology
Meta-analysis
PD-L1 expression shows subtype-specific prognostic value in skin neoplasms, meta-analysis finds
Does a common cancer marker predict survival in skin cancers? It depends
A meta-analysis of 24 observational studies found PD-L1 expression was not significantly associated with overall survival (HR=0.89, 95% CI: …
A common skin cancer marker doesn't predict survival for everyone, but it does for specific types like Merkel cell carcinoma and melanoma.
Apr 6, 2026
Oncology
FDA Approval
FDA Approves Zynyz (retifanlimab-dlwr) for Metastatic Anal Canal Cancer and Merkel Cell Carcinoma
FDA approves new drug Zynyz for two rare and aggressive types of cancer
The FDA has approved Zynyz, a PD-1 blocking antibody, for two indications: first-line treatment of inoperable locally recurrent or metastati…
FDA approves new drug Zynyz to treat two rare and aggressive cancers: advanced anal cancer and Merkel cell carcinoma.
FDA
Apr 2, 2026